Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5035168018 | Rosuvastatin zinc | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5035169014 | Rosuvastatin zinc (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rosuvastatin zinc | Is a | HMG-CoA reductase inhibitor | true | Inferred relationship | Some | ||
| Rosuvastatin zinc | Is a | Sulfonamide (substance) | false | Inferred relationship | Some | ||
| Rosuvastatin zinc | Is a | Pyrimidine | true | Inferred relationship | Some | ||
| Rosuvastatin zinc | Has disposition (attribute) | HMG-CoA reductase inhibitor | true | Inferred relationship | Some | ||
| Rosuvastatin zinc | Is modification of (attribute) | Rosuvastatin | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely ezetimibe 10 milligram and rosuvastatin (as rosuvastatin zinc) 10 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Rosuvastatin zinc | Inferred relationship | Some | 2 |
| Ezetimibe 10 mg and rosuvastatin (as rosuvastatin zinc) 20 mg oral capsule | Has precise active ingredient | True | Rosuvastatin zinc | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR